The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
On the Neuroendocrinopathy of Critical Illness. Perspectives for Feeding and Novel Treatments
Open accessAbstract
Typical for critical illnesses are substantial alterations within the hypothalamic-anterior pituitary-peripheral hormonal axes that are proportionate to the risk of poor outcome. These neuroendocrine responses to critical illness follow a biphasic pattern. The acute phase (first hours to days) is characterized by an increased release of anterior pituitary hormones, whereas altered target-organ sensitivity and hormone metabolism result in low levels of the anabolic peripheral effector hormones and contribute to the substantially elevated levels of the catabolic hormone cortisol. The prolonged phase of critical illness is hallmarked by a uniform suppression of the neuroendocrine axes, predominantly of central/hypothalamic origin, which contributes to the low (or insufficiently high in the case of cortisol) circulating levels of the target-organ hormones. Several of the acute-phase adaptations to critical illness are due to or accentuated by the concomitant fasting. Accepting the lack of macronutrients as well as the neuroendocrine responses to such fasting in the acute phase of critical illness has shown to beneficially affect outcome. In contrast, the neuroendocrine alterations that occur in the chronic phase of illness while patients are fully fed contribute to bone and skeletal muscle wasting and impose risk of adrenocortical atrophy. The combined administration of those hypothalamic releasing factors, which have been identified as suppressed or deficient during prolonged critical illness, may be a promising strategy to enhance recovery. The potential impact of treatment with such hypothalamic releasing factors on recovery from critical illness as well as on long-term rehabilitation should be investigated in future randomized controlled clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Physiological and Molecular Basis of Thyroid Hormone Action
Yen, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1097 · Cited by 2,011
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Early versus late parenteral nutrition in critically ill adults
Casaer, M. P., Mesotten, D., Hermans, G., Wouters, P. J., Schetz, M., Meyfroidt, G., Van Cromphaut, S., Ingels, C., Meersseman, P., Muller, J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102662 · Cited by 1,696
Regulation of the acute production of steroids in steroidogenic cells
STOCCO, D. M., & CLARK, B. J. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-221 · Cited by 1,057
Corticosteroid insufficiency in acutely ill patients
Cooper, M. S., & Stewart, P. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020529 · Cited by 1,033
Increased mortality associated with growth hormone treatment in critically ill adults
Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G., & Hinds, C. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411102 · Cited by 1,023
Annane, D. (2000) · JAMA · doi:10.1001/jama.283.8.1038 · Cited by 1,000
Measurements of Serum Free Cortisol in Critically Ill Patients
Hamrahian, A. H., Oseni, T. S., & Arafah, B. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa020266 · Cited by 726
Research works printed but not linked: 62
- Van den Berghe, 1998, Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms, J Clin Endocrinol Metab, 83, 1827
- Thorner, 1998, The anterior pituitary, 249
- Kojima, 1999, Ghrelin is a growth-hormone-releasing acylated peptide from stomach, Nature, 402, 656, 10.1038/45230 · DOI · Paper page
- Cowley, 2003, The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis, Neuron, 37, 649, 10.1016/S0896-6273(03)00063-1 · DOI · Paper page
- Bowers, 1984, On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone, Endocrinology, 114, 1537, 10.1210/endo-114-5-1537 · DOI · Paper page
- Howard, 1996, A receptor in pituitary and hypothalamus that functions in growth hormone release, Science, 273, 974, 10.1126/science.273.5277.974 · DOI · Paper page
- Baxter, 2001, Changes in the IGF-IGFBP axis in critical illness, Best Pract Res Clin Endocrinol Metab, 15, 421, 10.1053/beem.2001.0161 · DOI
- Van den Berghe, 2000, A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness, J Clin Endocrinol Metab, 85, 183
- Ross, 1991, Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I, Clin Endocrinol (Oxf), 35, 47, 10.1111/j.1365-2265.1991.tb03495.x · DOI · Paper page
- Baxter, 1998, Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients, Growth Horm IGF Res, 8, 455, 10.1016/S1096-6374(98)80298-0 · DOI
- Hermansson, 1997, Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: demonstration of reduced expression after elective surgery, J Clin Endocrinol Metab, 82, 421
- Defalque, 1999, GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors, Am J Physiol, 276, E565
- Van den Berghe, 1997, The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion, J Clin Endocrinol Metab, 82, 590
- Van den Berghe, 1998, Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues, J Clin Endocrinol Metab, 83, 309
- Van den Berghe, 1999, Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness, J Clin Endocrinol Metab, 84, 1311
- Friesema, 2005, Thyroid hormone transporters, Biochem Soc Trans, 33, 228, 10.1042/BST0330228 · DOI
- Chopra, 1985, Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3′-triiodothyronine in sera of patients with nonthyroidal illnesses, J Clin Endocrinol Metab, 60, 666, 10.1210/jcem-60-4-666 · DOI · Paper page
- Michalaki, 2001, Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery, J Clin Endocrinol Metab, 86, 4198
- Lim, 1993, Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids, J Clin Endocrinol Metab, 76, 1165
- Gardner, 1979, Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation, N Engl J Med, 300, 579, 10.1056/NEJM197903153001102 · DOI · Paper page
- Moshang, 1975, Low serum triiodothyronine in patients with anorexia nervosa, J Clin Endocrinol Metab, 40, 470, 10.1210/jcem-40-3-470 · DOI · Paper page
- Fivez, 2016, Early versus late parenteral nutrition in critically ill children, N Engl J Med, 374, 1111, 10.1056/NEJMoa1514762 · DOI · Paper page
- Hermans, 2013, Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial, Lancet Respir Med, 1, 621, 10.1016/S2213-2600(13)70183-8 · DOI · Paper page
- Gunst, 2013, Impact of early parenteral nutrition on metabolism and kidney injury, J Am Soc Nephrol, 24, 995, 10.1681/ASN.2012070732 · DOI
- Langouche, 2013, Impact of early nutrient restriction during critical illness on the nonthyroidal illness syndrome and its relation with outcome: a randomized, controlled clinical study, J Clin Endocrinol Metab, 98, 1006, 10.1210/jc.2012-2809 · DOI · Paper page
- Van den Berghe, 1997, Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues, Clin Endocrinol (Oxf), 47, 599, 10.1046/j.1365-2265.1997.3371118.x · DOI · Paper page
- Fliers, 1997, Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness, J Clin Endocrinol Metab, 82, 4032
- Bacci, 1982, The relationship between serum triiodothyronine and thyrotropin during systemic illness, J Clin Endocrinol Metab, 54, 1229, 10.1210/jcem-54-6-1229 · DOI · Paper page
- Damas, 1989, Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans, Crit Care Med, 17, 975, 10.1097/00003246-198910000-00001 · DOI · Paper page
- Faglia, 1973, Reduced plasma thyrotropin response to thyrotropin releasing hormone after dexamethasone administration in normal subjects, Horm Metab Res, 5, 289, 10.1055/s-0028-1093930 · DOI · Paper page
- Van den Berghe, 1994, Dopamine and the sick euthyroid syndrome in critical illness, Clin Endocrinol (Oxf), 41, 731, 10.1111/j.1365-2265.1994.tb02787.x · DOI · Paper page
- Van den Berghe, 1994, Dopamine suppresses pituitary function in infants and children, Crit Care Med, 22, 1747, 10.1097/00003246-199422110-00008 · DOI
- Alkemade, 2006, Novel neuroanatomical pathways for thyroid hormone action in the human anterior pituitary, Eur J Endocrinol, 154, 491, 10.1530/eje.1.02111 · DOI
- Langouche, 2013, Anterior pituitary morphology and hormone production during sustained critical illness in a rabbit model, Horm Metab Res, 45, 277
- Mebis, 2009, Expression of thyroid hormone transporters during critical illness, Eur J Endocrinol, 161, 243, 10.1530/EJE-09-0290 · DOI · Paper page
- Thijssen-Timmer, 2007, Thyroid hormone receptor isoform expression in livers of critically ill patients, Thyroid, 17, 105, 10.1089/thy.2006.0164 · DOI
- Van den Berghe, 2002, The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone, Clin Endocrinol (Oxf), 56, 655, 10.1046/j.1365-2265.2002.01255.x · DOI · Paper page
- Weekers, 2004, Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness, Endocrinology, 145, 205, 10.1210/en.2003-1005 · DOI
- Lebrethon, 1994, Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II, J Clin Invest, 93, 1828, 10.1172/JCI117168 · DOI
- Lehoux, 1989, Hormonal regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA in the rat adrenal gland, J Steroid Biochem, 34, 379, 10.1016/0022-4731(89)90112-X · DOI
- Lehoux, 1998, The acute and chronic effects of adrenocorticotropin on the levels of messenger ribonucleic acid and protein of steroidogenic enzymes in rat adrenal in vivo, Endocrinology, 139, 3913, 10.1210/endo.139.9.6196 · DOI
- Liu, 2000, Expression of low and high density lipoprotein receptor genes in human adrenals, Eur J Endocrinol, 142, 677, 10.1530/eje.0.1420677 · DOI
- Simpson, 1983, Regulation by ACTH of steroid hormone biosynthesis in the adrenal cortex, Can J Biochem Cell Biol, 61, 692, 10.1139/o83-088 · DOI · Paper page
- Miesfeld, 2001, Glucocorticoid action: biochemistry, 1647
- Burchard, 2001, A review of the adrenal cortex and severe inflammation: quest of the “eucorticoid” state, J Trauma, 51, 800, 10.1097/00005373-200110000-00033 · DOI
- Vermes, 1995, Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone, J Clin Endocrinol Metab, 80, 1238
- Marik, 2002, Adrenal insufficiency in the critically ill: a new look at an old problem, Chest, 122, 1784, 10.1378/chest.122.5.1784 · DOI · Paper page
- Pemberton, 1988, Hormone binding globulins undergo serpin conformational change in inflammation, Nature, 336, 257, 10.1038/336257a0 · DOI · Paper page
- Hammond, 1990, A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils, J Clin Endocrinol Metab, 71, 34, 10.1210/jcem-71-1-34 · DOI · Paper page
- Finlay, 1982, Serum cortisol levels in severely stressed patients, Lancet, 1, 1414, 10.1016/S0140-6736(82)92531-4 · DOI
- Rothwell, 1991, Cortisol response to corticotropin and survival in septic shock, Lancet, 337, 582, 10.1016/0140-6736(91)91641-7 · DOI · Paper page
- Span, 1992, Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients, Intensive Care Med, 18, 93, 10.1007/BF01705039 · DOI
- Annane, 2002, Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock, JAMA, 288, 862, 10.1001/jama.288.7.862 · DOI · Paper page
- Sam, 2004, Cortisol levels and mortality in severe sepsis, Clin Endocrinol (Oxf), 60, 29, 10.1111/j.1365-2265.2004.01923.x · DOI · Paper page
- Vermes, 2001, The hypothalamic-pituitary-adrenal response to critical illness, Best Pract Res Clin Endocrinol Metab, 15, 495, 10.1053/beem.2001.0166 · DOI
- Deutschman, 2013, Orexinergic activity modulates altered vital signs and pituitary hormone secretion in experimental sepsis, Crit Care Med, 41, e368, 10.1097/CCM.0b013e31828e9843 · DOI
- Boonen, 2014, Impact of duration of critical illness on the adrenal glands of human intensive care patients, J Clin Endocrinol Metab, 99, 4214, 10.1210/jc.2014-2429 · DOI
- Karpac, 2008, Failure of adrenal corticosterone production in POMC-deficient mice results from lack of integrated effects of POMC peptides on multiple factors, Am J Physiol Endocrinol Metab, 295, E446, 10.1152/ajpendo.00762.2007 · DOI
- Barquist, 1997, Adrenal insufficiency in the surgical intensive care unit patient, J Trauma, 42, 27, 10.1097/00005373-199701000-00006 · DOI
- Sprung, 2008, Hydrocortisone therapy for patients with septic shock, N Engl J Med, 358, 111, 10.1056/NEJMoa071366 · DOI · Paper page
- Mesotten, 2008, The altered adrenal axis and treatment with glucocorticoids during critical illness, Nat Clin Pract Endocrinol Metab, 4, 496, 10.1038/ncpendmet0921 · DOI
- van den Berghe, 2001, Intensive insulin therapy in critically ill patients, N Engl J Med, 345, 1359, 10.1056/NEJMoa011300 · DOI · Paper page
Cited by
Vanhorebeek, I., Latronico, N., & Van den Berghe, G. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05944-4 · Cited by 717
Self-citationLong-term outcomes after critical illness: recent insights
Rousseau, A.-F., Prescott, H. C., Brett, S. J., Weiss, B., Azoulay, E., Creteur, J., Latronico, N., Hough, C. L., Weber-Carstens, S., Vincent, J.-L., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03535-3 · Cited by 314
Reignier, J., Plantefeve, G., Mira, J.-P., Argaud, L., Asfar, P., Aissaoui, N., Badie, J., Botoc, N.-V., Brisard, L., Bui, H.-N., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00092-9 · Cited by 270
The ICM research agenda on intensive care unit-acquired weakness
Latronico, N., Herridge, M., Hopkins, R. O., Angus, D., Hart, N., Hermans, G., Iwashyna, T., Arabi, Y., Citerio, G., Wesley Ely, E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4757-5 · Cited by 256
Self-citationNtali, G., & Tsagarakis, S. (2019) · Pituitary · doi:10.1007/s11102-019-00944-0 · Cited by 29
Metadata
- Authors
- Van den Berghe, G.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-12-01
- Volume
- 194
- Issue
- 11
- Pages
- 1337-1348
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2508756596
- Cited by
- 107
- References
- 37
- FWCI
- 7.22
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- Research Foundation Flanders (G041712N)
- Methusalem Program of the Flemish Government (METH/14/06)
- European Research Council (FP7/2013-2018)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: On the Neuroendocrinopathy of Critical Illness. Perspectives for Feeding and Novel Treatments. https://app.cochat.ai/papers/10.1164/rccm.201607-1516ci
- The paper
- Van den Berghe, G. (2016). On the Neuroendocrinopathy of Critical Illness. Perspectives for Feeding and Novel Treatments. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201607-1516ci
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.